Advice
Medicine discontinued
On 31 March, 2024, exenatide (Byetta®), 5 micrograms & 10 micrograms, solution for injection, prefilled pen was discontinued.
Medicine details
- Medicine name:
- exenatide (Byetta)
- SMC ID:
- 785/12
- Indication:
Adjunctive therapy to basal insulin with or without metformin and/or pioglitazone in adults who have not achieved adequate glycaemic control with these agents.
- Pharmaceutical company
- Lilly UK
- BNF chapter
- Endocrine system
- Submission type
- Full
- Status
- Withdrawn
- Date advice published
- 11 June 2012
Additional notes
On 31 March, 2024, exenatide (Byetta®), 5 micrograms & 10 micrograms, solution for injection, prefilled pen was discontinued.